NCT01860703View on ClinicalTrials.gov

Evaluation of Whether Deferiprone Affects QT Interval in Healthy Subjects

PHASE4CompletedINTERVENTIONAL

Enrollment

50

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

December 31, 2012

Study Completion Date

July 31, 2013

Conditions

Prolonged QTc Interval

Interventions

DRUG

Deferiprone

Ferriprox 500 mg tablets

DRUG

deferiprone matching placebo tablets

deferiprone matching placebo tablets

DRUG

moxifloxacin

Active control

DRUG

placebo

moxifloxacin-matching placebo

Trial Locations (1)

85283

Celerion, Tempe

Sponsors

Lead Sponsor

All Listed Sponsors

lead

ApoPharma

INDUSTRY

NCT01860703 - Evaluation of Whether Deferiprone Affects QT Interval in Healthy Subjects | Biotech Hunter | Biotech Hunter